Article Text
Prognosis
Cohort study
Digoxin initiation is associated with lower risk of all-cause readmission after hospitalisation for heart failure
Statistics from Altmetric.com
Commentary on: OpenUrlCrossRefPubMed
Context
The use of digoxin for the treatment of heart failure dates back to the 18th century, yet controversy remains about its safety and efficacy. The largest clinical trial of digoxin concluded that digoxin had no effect on mortality but did improve the rate of rehospitalisation for patients with chronic heart failure.1 With increasing focus on readmissions, there are limited data to understand the impact of digoxin initiated during hospitalisation for acute heart failure on postdischarge outcomes.
Methods
The authors analysed data from chart abstractions and Medicare claims of patients hospitalised with acute heart failure to assess the impact of digoxin on postdischarge …
Footnotes
-
Competing interests None.